Direct Injection Technologies
Share on
Direct Injection Technologies Using technology to deliver a more efficient, effective and cheaper method to supplement livestock.
  • Environment and Clean Tech
  • Manufacturing
  • Agriculture
OVERFUNDING!

Minimum subscription hit - More equity on offer.!

  • A$639,000

    invested

  • 159.8% funded

  • 3 days & 13 hours

    time left

  • 4.3% - 10.9%

    min - max equity offered

  • A$400,000.00 - A$1,100,000.00

    min - max investment sought

  • A$250.00

    min investment parcel

INVEST IN THIS OFFER
Dividedn

Mark

Thank you for your presentation

Will DIT pay a dividend to investors?

James

James Athanasou posted on 14.02.2019

Hi James

At this stage we have not decided to pay dividends all profits will go back into the business to scale and grow it for our shareholders.

That is not to say in time we wont but not for a few years.

Thanks

Mark

Mark Peart posted on 15.02.2019

Replied to James Athanasou

Acquisition of Harrington Systems Electronics

Hi Mark,

I'm interested in whether there are any implications for prospective shareholders when it comes to the merger of DIT and HSE, which should be disclosed to investors.

For example, were there any new shares issued or sold for the acquisition, or monetary transfers involved that would alter the business from how it appears in the Offer Document?

https://www.facebook.com/directinjectiontechnologies/posts/1330664603742650?__tn__=K-R

Kind regards,

Michael

Michael Horner posted on 13.02.2019

Hello Michael

Quite the opposite we are doing a staged approached to the purchase and we will be issuing shares to HSE at a much higher valuation than what we have placed on the enterprise for this round.

It will dilute investors like any round, I will be diluted also but the increase in value of the current shareholders shares from a increased valuation due to the synergies and earning potential are what the Board are looking at. But most importantly we are wanting to add value to our customers and offer a wider range of livestock technology that drives their profitability.

If you would like to ring me I be happy to discuss in more detail.

Thanks

Mark
0412 599342

Mark Peart posted on 15.02.2019

Replied to Michael Horner

Technology and geographic expansion

Hi Mark,

Thanks for the recent webinar, I've had a watch and it's left me with a couple of questions.

You mention the global market a few times, but when you addressed your future growth specifically discussed technology or product diversity rather than geographical expansion. Is this solely limited by your current patent situation, or do you see other risks in the international market that would prevent this type of growth? In particular, are there key risks you see in the South American market that would prevent near term expansion to Brazil, Argentina etc.

On the technology front, do you have any referenceable content (video, articles) that demonstrates the dosing system in action? I'd like to understand the devices further, and in particular if they are network connected. Do you see your customers being interested in a digital management for dosing?

Finally, roughly what split of revenue currently exists across your annuity, once off, and services streams? What have been the rough growth trend of each of these to date?

Thanks in advance for your time and energy spent answering.

Steve Godbold posted on 09.02.2019

Hi Steve

Thanks for your question and interest in DIT

In regards to your first question; when the time comes to expand into the Global markets specially North and South America we want to have a solid footprint and strong robust model that works here in Australia, we are currently expanding our patent protection to these markets. North America offers great scope and scale the issue with South America will always be the low wages cost there and being able to scale with innovation compared with low wages and manual supplement.

Yes we do have video of the dosing units and happy to send to you please send me a email to our web site and I will share or happy to do a one on one FaceTime and show you some in action. And to your second question here yes we do remote monitoring and network connection and have clients who use it now. You will notice in our offer document we talk about the MOU we have entered into to buy another business which has a great remote monitoring platform and current customers. We are well advanced already moving all our doses over to it. http://www.usee.com/

Lastly your question about revenue streams; to put in perspective one unit on average supplements 500 head of cattle so that is a $10000 buy and or monthly rent of of $295 if the customer rents which most are moving to. Supplement costs are on going and on average revenue is approx 10cents per hear per day or $50 per day for 500 head. The units will last with regular servicing up to 10 years we believe. Once we engage talent and have sales/extension staff on the road I see this growth expanding rapidly. Selling any tech into this remote market is about human interaction and service you will not get scale and growth without service and face to face interaction.

Hope that helps and by all means call me if you like my number is 0412 599342

Thanks and hope you become a shareholder with myself and my other early stage shareholders.

Mark

Mark Peart posted on 09.02.2019

Replied to Steve Godbold

Terra Nurti

Thanks Mark. Would you consider Terra Nutri a competitor? I don't believe they are in Australia yet but have ambitions for Asia Pacific region. Pardon my ignorance, but what do you mean by no one can inject Phosphorus into water 100% safely. Obviously Terra Nutri do Phosphorus so I would be keen to get a better understanding. Is the "safety" aspect of injecting part of your IP and how defendable is it?. Website for Terra Nutri is below:

http://www.terranutritech.com/minerals.html

John Graham posted on 07.02.2019

Thanks John

I am aware of this company.

The supplements they deliver are in small amounts and not in the volumes we supplement to livestock in Australia. Additionally we also use Urea as our base and as such this is toxic if not administered safely.

The company you speak of are in Ireland and do not operate in the same market as us, I understand that it may seem they do but there is a very big difference in large scale livestock production in Australia and North and South America compared to the more intensive production of Europe and Britain.

Hope that helps

MP

Mark Peart posted on 07.02.2019

Replied to John Graham

Customer Retention Rate

Hi Mark,

I'm very interested to see from the sales figures that the proportion of revenue from both the sale of supplements and equipment is on a significant incline.

Do you have any information regarding the retention of customers who have installed water injection systems? In other words, are there any cases where farmers have chosen to install a system, and subsequently abandoned its usage?

Michael Horner posted on 06.02.2019

Hello Michael

Thank you for your questions.

I can say since we have been in operation I do not know of any customers that have abandoned our products and or tech.

In fact the opposite was we travel seeing more and more farmers we come across farmers that had used the technology some time ago ( more than 15 years) with little success. Once we present to them all the changes we have made and safe guards all ask if we can refurb their old doses from 15 years ago. Of course we cant as things have changed so much but ones that abandoned the tech many years ago come straight back on board when they see all the changes and value it now offers

Hope that answers your question

MP

Mark Peart posted on 07.02.2019

Replied to Michael Horner

Direct Competitors

One of the risks you mention in the IM is that competitors switch to liquid injected nutrients....Are their any competitors either in Australia or Globally that are currently manufacturing liquid Injected Nutrients?
Thank you

John Graham posted on 06.02.2019

Hi John

Thanks for your question.
Yes there are other stock feed businesses that put supplements into the water but none that proportionally injects into water it is very much a guess on the application.
But there is no one that injections Urea or Phosphorus into drinking water in the world that can provide 100% safety. All cattle and sheep that are supplemented currently with Urea and Phosphorus are done in the form of lick blocks and or dry lick with is expensive and time consuming plus it is impossible to control the dose rate accurately.
Hope that answered your question.
Thanks

Mark

Mark Peart posted on 06.02.2019

Replied to John Graham

  • > Offer Type: Australian Retail (CSF) Offer This offer is open to Retail and Wholesale/Sophisticated investors in Australia. Whilst in New Zealand the offer is open to Wholesale investors.
  • > Company: D.I.T Technologies Limited Securities purchased are for direct equity in D.I.T Technologies Limited.
  • > Security Type: Ordinary Shares
  • > Fees Paid by Issuer: 6.00% of funds raised Upon successful completion of this funding round a total of 6.00% of capital raised will be paid by the Issuer to Equitise.
  • > Cooling-Off Rights: 5 working days - Retail investors in Australia are able to withdraw their applications for securities with accordance to the Australian Crowd Source Funding (CSF) regulations. For more information please click on the link supplied.
    More Info
  • > Related Parties: None

More detailed information about this offer is contained in this Offer Document

Offer Document
Offer overview

 

The Company is offering 800,000 to 2,200,000 ordinary shares under the following terms:

 

Executive summary

 

Direction Injection Technologies (DIT) provides supplements to livestock through drinking water. DIT is using its technology to provide a more efficient, effective and cheaper method to supplement livestock, reducing the daily cost from an average of 40c to 8c per animal daily.*

 

We provide both the technology, being the proportional dosing mechanism, as well as the specially formulated supplements themselves. Owning both the technology and supplements are differentiating facets and tangible assets of the DIT model. To protect these aspects of the business the company has 1 patent granted and 3 patents pending (please see section 2.4.4 of the Offer Document for more detail).

 

Whilst DIT is immediately focusing on domestic markets, there are global applications of the DIT technology and formulas. With a foothold in the Australian market, DIT intends to expand into major agricultural markets such as the US, South America and New Zealand.

*Please note these figures are based off real average cost savings experienced by existing DIT customers.

 

INVESTMENT HIGHLIGHTS 

 

Business model

 

OVERVIEW

 

The DIT business model has two primary revenue streams. DIT develops and sells the dispensing system to farmers generating revenue on each sale. DIT also generates recurring revenue by providing the supplements to be dispensed via the dispensing system.

 

 
PRODUCT RANGE

 

Technology Systems

 

 

  • Nutridose: The Nutridose is a proportional dosing dispenser for water-soluble supplements to cattle and sheep and is DIT's flagship technology offering. It is the only system on the market specifically designed to safely feed urea into livestock drinking water.

  • Promatic: The Promatic is a portable water supplementing system utilising a peristaltic pump. It is compatible with a variety of livestock situations, including pasture, yards and pens.

  • Nutripro: The Nutripro is a hybrid unit that combines elements of the Nutridose and the Promatic to create a more mobile unit without compromising dosing accuracy. 

  • Medipro: The Medipro is a small proportional dosing unit designed for intensive livestock production systems such as dairies, piggeries and poultry sheds. 

 

Supplements

 

 

  • uPro: uPro is a scientifically formulated blend designed to supplement urea to livestock as a water-soluble feed additive. 

  • uPhos: uPhos provides a rapidly soluble source of 100% available phosphorus and urea through water medication.

  • uTrace: uTrace is a water-soluble formulation containing all the major trace elements required by cattle, sheep and goats.

  • uCalm and uCalm Export: uCalm and uCalm Export contain glucose, electrolytes and trace elements to assist with and prevent dehydration in cattle, sheep and goats during times of stress, such as weaning, yarding, transportation and induction.

 

INTELLECTUAL PROPERTY

 

As the dosing units and formulas are novel and proprietary to DIT, the company has 1 patent granted and 3 patents in the pending stage (as displayed below). Most recently, the provisional application for urea compositions as animal feeds has been granted a patent application number AU2018903768 and was filed on October 9, 2018.

 

The intellectual property actions have been outlined below in terms of product and patent status.

 

Milestones & History

 

Strategy & Vision

 

 

OVERVIEW

 

The core business strategy of DIT is about making Australian farmers produce high quality, sustainable food. To do this DIT intend to build a knowledgeable ecosystem of talent to deploy technology, services and products across the value chain to Australian farmers.

 

GROWTH STRATEGY

 

DIT will move quickly to capitalise on its critical first-mover advantage in the water supplementation space through a rapid expansion in premises and scale. 

 

Micro Factories & Warehouses

 


DIT intends to establish micro factories and warehouses across Australia in Townsville, Darwin, Perth and Melbourne in the next three years. These locations have been chosen to cover key sales areas and for accessibility to ports for raw commodities. 

 

Extension Officers

 

DIT will hire a team of specialised agricultural science graduates to be trained as sales representatives. It is anticipated that this personalised customer service will forge stronger relationships with clients and provide opportunities to offer a range of consulting services.

 

Acquisition Strategy

 

DIT made a strategic acquisition of Pastoral and Feedlot Systems Australia (PFSA) which gave DIT ownership of the product range and IP owned by PFSA and key personnel. As DIT grows, it will explore additional acquisition opportunities to compliment the core offerings of DIT.

 

Developing New Revenue Streams

 

The principles of proportional dosing can be applied to many other related industries. DIT has developed and are looking to deploy the Medipro, a small, inexpensive proportional doser for medicating pigs and poultry. Additionally, DIT will commercialise the Chemject, a proportional dosing system for chemicals that bolts onto farm tractors, removing the need for manual mixing of chemicals.

Use of funds

 

The table below sets out the intended use of funds raised under this Offer based on the minimum and maximum subscription amounts (for further information please see section 3.3 of the Offer Document).

 

Risks Facing The Business

 

A description of the main risks that may impact our business is below.

 

For a detailed breakdown of the key risks please see section 2.17 of the Offer Document.

 

Financial summary

 

Historically the Company has operated as a proprietary limited business (Direct Injection Systems Pty Ltd.), as part of the crowd sourced funding campaign the Directors have decided to transition to a public unlisted company (D.I.T. Technologies Ltd.). As at 31 October 2018, the proprietary limited business (and its associated IP) was acquired by the public unlisted company (D.I.T. Technologies Ltd.).

 

For a period the proprietary and public unlisted entities were operating in parallel. As such we have shown management accounts for both entities and also for the consolidated results from 1st July through to October 31st 2018.

 

For a full breakdown of the financials and forecasts please see sections 2.13 and 2.16 of the Offer Document.

 

 

 

1. Current assets include the purchase of PFSA business during 2017, with corresponding vendor finance liabilities on this purchase included in non-current liabilities.

2. Two motor vehicles and minor office equipment purchases have occurred in the July – October 2018 period. The Mitsubishi Tritons have been financed by Chattel Mortgage and the balance of these loans is reflected in the liabilities.

3. $115,000 is for professional fees, establishment and other associated costs in relation to the establishment of the public company.

4. Trade Creditors of $110k reflects balance of payables for trade purchases. Of these payables, 80% are less than 30 days.

5. Other current liabilities includes current GST and PAYG(W) payable balances.

Mark Peart

See profile
Alison Gravolin

See profile
Tom Feez

See profile
Susannah McInnerney

See profile
Ana Cristy Bianzon

See profile

Direct Injection Technologies Offer Document

This is the D.I.T. Technologies Ltd. Offer Document as at 23 November 2018.

Download

The investors below have committed capital to the business in this funding round.

Michael Mangion

15-02-2019

See profile
Gordon Dyball

15-02-2019

See profile
Paul Matthews

15-02-2019

See profile
Martin Connolly

14-02-2019

See profile
ilic86

14-02-2019

Jonathan McLean

13-02-2019

See profile
Danial Robbins

13-02-2019

See profile
Yergan Henwood

12-02-2019

See profile
Stewart Addison

11-02-2019

See profile
Ron Edwards

11-02-2019

See profile
SMSF

11-02-2019

Luanne Damiao

11-02-2019

See profile
Conor Hilton

10-02-2019

See profile
Chris

10-02-2019

Aaron Collins

09-02-2019

See profile
Ramchandra Dahal

09-02-2019

See profile
Richard Lindley

09-02-2019

See profile
Brenton Henwood

08-02-2019

See profile
James Henwood

08-02-2019

See profile
Paul Smith

08-02-2019

See profile
Michael MMR

08-02-2019

See profile
Nick M

07-02-2019

D & S McKenna

07-02-2019

Graemec

07-02-2019

SONYA VELTMAN

06-02-2019

See profile
Ilona Charles

05-02-2019

See profile
Kirill Reztsov

05-02-2019

See profile
Margaret Lee-Madigan

05-02-2019

See profile
Annette Smith

05-02-2019

See profile
Debojyoti Sarker

05-02-2019

See profile
Rick Egan

05-02-2019

See profile
NeneB

04-02-2019

Charles De Guzman

04-02-2019

See profile
dinnes

04-02-2019

T2V

04-02-2019

Lindsay Jolley

01-02-2019

See profile
Muyiwa Olayemi

01-02-2019

See profile
Jack Hilton

01-02-2019

See profile
benjamin norris

01-02-2019

See profile
Dry Gully

01-02-2019

SFIT

01-02-2019

Emubitter

01-02-2019

Sam Telford

01-02-2019

See profile
Vivienne McCollum

01-02-2019

See profile
Rodney Hopkins

01-02-2019

See profile
Faisal Muhammad

01-02-2019

See profile
Brendan Goleby

31-01-2019

See profile
Fox

31-01-2019

Michael McKay

31-01-2019

See profile
Brendan Kent

30-01-2019

See profile
Private SMSF Fund

30-01-2019

Bryan Graham

29-01-2019

See profile
1212

29-01-2019

Sean Hegarty

29-01-2019

See profile
Oliver Ryan

29-01-2019

See profile
Peter Cozens

29-01-2019

See profile
Jin Lim

29-01-2019

See profile
Russell Khan

29-01-2019

See profile
Marc Hillary

29-01-2019

See profile
Stewart Webster

28-01-2019

See profile
Andrew A

27-01-2019

Luke Willey

25-01-2019

See profile
Joshua Welke

25-01-2019

See profile
Akash Goyal

24-01-2019

See profile
Andrew Bourne

24-01-2019

See profile
Paul Creighton ATF Creighton Holdings Trust

24-01-2019

See profile
Alison Welke

24-01-2019

See profile
KG

23-01-2019

Damon

23-01-2019

Mt Mee Farmer

23-01-2019

Rob Johnson

23-01-2019

See profile
Noelene Howe

23-01-2019

See profile
Joseph Freeman

23-01-2019

See profile
Tiana Freeman

23-01-2019

See profile
ABCD1234

23-01-2019

Stephen Breen

23-01-2019

See profile
ANTHONY GERALD CABUTOTAN

22-01-2019

See profile
Douglas Spiegelhauer

22-01-2019

See profile
Hormazd Dastur

22-01-2019

See profile
Ritesh Sunderji Gosar

22-01-2019

See profile
dannylee3276

22-01-2019

Michael Lehmann

22-01-2019

See profile
Guy Keats

22-01-2019

See profile
Joshua Greene

22-01-2019

See profile
Timothy Matthews

17-01-2019

See profile
Andrew Mac

13-01-2019

Alison Gravolin

03-01-2019

See profile
Jeffrey Mays

19-12-2018

See profile
Beatrice Cameron

12-12-2018

See profile
Janelle Ramsey

11-12-2018

See profile
Kim Harris

07-12-2018

See profile
Bruce Montgomery

05-12-2018

See profile
Amanda Kenafake

30-11-2018

See profile
Dugald Storie

30-11-2018

See profile
RANDALL EVANS

29-11-2018

See profile
Kurt Byrnes

24-11-2018

See profile
Kelly Ostwald

24-11-2018

See profile

To see the rest of the Direct Injection Technologies offer, join now.
It’s free, quick and easy.

JOIN

Already registered?

To see the rest of the Direct Injection Technologies offer, join now.
It’s free, quick and easy.

Direct Injection Technologies

Join to read more information about the Direct Injection Technologies team, documents, and what other investors are saying about the offer.

If you have any questions about equity crowdfunding or the account creation process please write us an email at contact@equitise.com or post it in the live chat box at the bottom of the screen.

 


 


Log in to find out more


Login Register

Please make sure you have saved your campaign before leaving this page